z-logo
open-access-imgOpen Access
HIV MDR is still a relevant issue despite its dramatic drop over the years
Author(s) -
Daniele Armenia,
Domenico Di Carlo,
Philippe Flandre,
Yagaï Bouba,
Vanni Borghi,
Federica Forbici,
Ada Bertoli,
Caterina Gori,
Lavinia Fabeni,
William Gennari,
Carmela Pinnetti,
Annalisa Mondi,
Stefania Cicalini,
Roberta Gagliardini,
Alessandra Vergori,
Rita Bellagamba,
Vincenzo Malagnino,
Francesco Montella,
Manuela Colafigli,
Alessandra Latini,
R. Marocco,
M Licthner,
Massimo Andreoni,
Cristina Mussini,
Francesca CeccheriniSilberstein,
Andrea Antinori,
Carlo Federico Perno,
Maria Mercedes Santoro
Publication year - 2019
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkz554
Subject(s) - medicine , drug resistance , hiv drug resistance , proportional hazards model , hazard ratio , regimen , human immunodeficiency virus (hiv) , genotype , antiretroviral therapy , cumulative risk , viral load , immunology , confidence interval , biology , genetics , gene
To evaluate the prevalence and therapeutic relevance of drug resistance among isolates from ART-experienced HIV-1-infected patients over the past two decades in Italy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom